Clinical Trial Update: A Study of LY2409021 on Blood Pressure and Pulse Rate in Participants With Type 2 Diabetes Mellitus [Phase 2]

View source ↗

Summary

A Phase 2 study of LY2409021 in adults with Type 2 Diabetes Mellitus assessing blood pressure and pulse rate has completed and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• LY2409021

Snippet

Sponsor: Eli Lilly and Company | Conditions: Type 2 Diabetes Mellitus | Phase 2 | Status: COMPLETED | Results posted: 2018-07-19